Skip to main content
COVID-19
Actuarial View of COVID-19: Payers, Providers, and Healthcare Reform
Read More
Lung Cancer, FDA Updates
Opdivo plus Yervoy and Chemotherapy Approved as First-Line Therapy for Metastatic NSCLC, Regardless of PD-L1 Expression
Read More
Hepatocellular Carcinoma, FDA Updates
Tecentriq plus Avastin First Immunotherapy Regimen Approved for Metastatic Hepatocellular Carcinoma
Read More
Prostate Cancer, FDA Updates
Lynparza First Targeted Therapy Approved for Metastatic Prostate Cancer with HRR Mutation
Read More
Lung Cancer, FDA Updates
Tecentriq Approved as First-Line Therapy for Metastatic NSCLC with High PD-L1 Expression
Read More
COVID-19
Washington and COVID-19: The Government Response
Read More
COVID-19
Oncology Nurse Navigators Take on COVID-19 Challenge
Read More
Online Only
COVID-19
The Impact of COVID-19 on Cancer Research and Investigational Studies
Read More
Online Only
COVID-19
COVID-19: Impact on Telehealth
Read More
Online Only
COVID-19
Employers and the Impact of COVID-19
Read More
Page 133 of 196
Results 1321 - 1330 of 1954